Category Pharmaceutical Industry

North Dakota to Receive Nearly $3 Million in Whistleblower Lawsuit [Legal Monitor Worldwide]

Dec31

The state of North Dakota will be receiving nearly $3 million for its state Medicaid program as part of a whistleblower settlement between the federal government and a major pharmaceutical company.A Tuesday release from the North Dakota Department of Human Services announced that the state Medicaid program will receive about $2.99 million. The money comes […]

IGI Laboratories, Inc. Completes Its Sixth ANDA Filing For 2013 Under Joint Drug Development And Commercialization Agreement

Dec31

BUENA, N.J., Dec. 31, 2013 /PRNewswire/ IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based generic topical pharmaceutical company, today announced it executed a license, development, supply and marketing agreement with a large multi-national pharmaceutical company. In accordance with the confidentiality agreement in place, the name of the company remains undisclosed. The agreement designates […]

Enanta Pharmaceuticals Inc. Files SEC Form 4, Statement of Changes in Beneficial Ownership of Securities (Dec. 13, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Enanta Pharmaceuticals Inc. (Form 4) was posted on December 13, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There was one document filed with […]

Pennsylvania Pharmacists Seek Legislative Relief from Abuses by Drug Plan Middlemen

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week Pennsylvania jobs, revenue and pharmacies are under attack by obscure, yet powerful, pharmaceutical corporate middlemen and the state’s independent community pharmacists say the best hope for relief is enacting legislation during the 2014 legislative session, the National Community Pharmacists Association (NCPA) said (see also Pharmaceutical […]

Synta Pharmaceuticals Corp. Files SEC Form SC 13D, General Statement of Acquisition of Beneficial Ownership [Amend] (Dec. 16, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Synta Pharmaceuticals Corp. (Form SC 13D) was posted on December 16, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There was one document filed […]

Momenta Pharmaceuticals Inc. Files SEC Form 3, Initial Statement of Beneficial Ownership of Securities (Dec. 12, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Momenta Pharmaceuticals Inc. (Form 3) was posted on December 12, 2013.The SIC code for this company is 2836, Biological Products, (No Diagnostic Substances).There were 2 […]

Patent Issued for Use of an Adrenal Hormone-Modifying Agent

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week Novartis AG (Basel, CH) has been issued patent number 8609862, according to news reporting originating out of Alexandria, Virginia, by NewsRx editors (see also Pharmaceutical Companies).The patent’s inventors are Hu, Qi-Ying (Needham, MA); Ksander, Gary Michael (Amherst, NH); Meredith, Erik (Hudson, MA); Monovich, Lauren G. […]

MicroBiome Therapeutics Updates on Completion of Bridge Financing [Professional Services Close

Dec30

MicroBiome Therapeutics, (MBT) announced completion of a $1.3 million bridge financing.In a release, the company noted that it is intended to support completion of the company’s two ongoing clinical studies and preparations for further clinical trials of lead product NM504, a microbiome modulator in development for type 2 diabetes and prediabetes. The bridge financing was […]

Transcept Pharmaceuticals Inc. Files SEC Form 8-K, Current Report (Dec. 17, 2013)

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a U.S. Securities and Exchange Commission (SEC) filing by Transcept Pharmaceuticals Inc. (Form 8-K) was posted on December 17, 2013.The SIC code for this company is 2834, Pharmaceutical Preparations.There were 3 documents filed with […]

Researchers Submit Patent Application, “Safety Device for a Pre-Filled Syringe and an Injection Device”, for Approval

Dec30

By a News Reporter-Staff News Editor at Pharma Business Week From Washington, D.C., NewsRx journalists report that a patent application by the inventors Roberts, Gareth (Wrexham, GB); Ekman, Matthew (Cheshire, GB), filed on December 30, 2011, was made available online on December 19, 2013 (see also Pharmaceutical Companies).The patent’s assignee is Sanofi-aventis Deutschland Gmbh.News editors […]